Race Oncology’s Board of Directors Roundtable
Join the Race Oncology Board for an in-depth roundtable discussion on the company’s mission, scientific breakthroughs, and strategic roadmap. Hear from Dr Peter Smith, Dr Serge Scrofani, Dr Megan Baldwinand and Dr Daniel Tillett as they explore:
How Race Oncology’s patient-focused mission drives decision-making
Recent milestones, including IP advancements and mechanism of action insights
The evolving oncology landscape and Race’s unique position
Commercial opportunities, partnering strategies, and global ambitions
Personal reflections from board members on resilience, governance, and innovation
This conversation offers a rare behind-the-scenes look at how Race Oncology is shaping the future of cancer treatment.
Watch here: https://youtu.be/nfM6VTBTwYQ
0
likes
•
0
questions
•
0
company answers
Ask a question
Your question will be sent privately to Racura Oncology. The company may choose to make this question public.
Investor Q&As
Start the conversation
Ask Racura Oncology a question about this update.